BIOMAT Database Logo BIOMAT Database Logo

Phase I study of weekly maytansine given by iv bolus or 24-hour infusion. 1979

A P Chahinian, and C Nogeire, and T Ohnuma, and M L Greenberg, and M Sivak, and I S Jaffrey, and J F Holland

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D007275 Injections, Intravenous Injections made into a vein for therapeutic or experimental purposes. Intravenous Injections,Injection, Intravenous,Intravenous Injection
D008099 Liver A large lobed glandular organ in the abdomen of vertebrates that is responsible for detoxification, metabolism, synthesis and storage of various substances. Livers
D008297 Male Males
D008453 Maytansine An ansa macrolide isolated from the MAYTENUS genus of East African shrubs. Maitansine,DMMO-Maytansine,Emtansine,Maytansinoid DM1,Maytansinoid DM4,Mertansine,N2'-Deacetyl-N2'-(4-mercapto-4-methyl-1-oxopentyl)maytansine,Ravtansine,Soravtansine,DM1, Maytansinoid,DM4, Maytansinoid,DMMO Maytansine
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D009420 Nervous System The entire nerve apparatus, composed of a central part, the brain and spinal cord, and a peripheral part, the cranial and spinal nerves, autonomic ganglia, and plexuses. (Stedman, 26th ed) Nervous Systems,System, Nervous,Systems, Nervous
D010078 Oxazines Six-membered heterocycles containing an oxygen and a nitrogen.
D001853 Bone Marrow The soft tissue filling the cavities of bones. Bone marrow exists in two types, yellow and red. Yellow marrow is found in the large cavities of large bones and consists mostly of fat cells and a few primitive blood cells. Red marrow is a hematopoietic tissue and is the site of production of erythrocytes and granular leukocytes. Bone marrow is made up of a framework of connective tissue containing branching fibers with the frame being filled with marrow cells. Marrow,Red Marrow,Yellow Marrow,Marrow, Bone,Marrow, Red,Marrow, Yellow

Related Publications

A P Chahinian, and C Nogeire, and T Ohnuma, and M L Greenberg, and M Sivak, and I S Jaffrey, and J F Holland
Phase I/pharmacokinetic study of topotecan by 24-hour continuous infusion weekly.
March 1994, Cancer research,
A P Chahinian, and C Nogeire, and T Ohnuma, and M L Greenberg, and M Sivak, and I S Jaffrey, and J F Holland
Initial clinical study with vindesine: tolerance to weekly iv bolus and 24-hour infusion.
January 1980, Cancer treatment reports,
A P Chahinian, and C Nogeire, and T Ohnuma, and M L Greenberg, and M Sivak, and I S Jaffrey, and J F Holland
Phase I trial of 5-fluorouracil by 24-hour infusion weekly.
January 1993, Investigational new drugs,
A P Chahinian, and C Nogeire, and T Ohnuma, and M L Greenberg, and M Sivak, and I S Jaffrey, and J F Holland
NCIC CTG IND.181: phase I study of AT9283 given as a weekly 24 hour infusion in advanced malignancies.
December 2013, Investigational new drugs,
A P Chahinian, and C Nogeire, and T Ohnuma, and M L Greenberg, and M Sivak, and I S Jaffrey, and J F Holland
Phase I trial of ilmofosine as a 24 hour infusion weekly.
January 1995, Investigational new drugs,
A P Chahinian, and C Nogeire, and T Ohnuma, and M L Greenberg, and M Sivak, and I S Jaffrey, and J F Holland
Phase I study of recombinant beta-interferon given by four-hour infusion.
February 1987, Cancer research,
A P Chahinian, and C Nogeire, and T Ohnuma, and M L Greenberg, and M Sivak, and I S Jaffrey, and J F Holland
A phase I pharmacologic and pharmacodynamic study of pyrazoloacridine given as a weekly 24-hour continuous intravenous infusion in adult cancer patients.
July 2002, Clinical cancer research : an official journal of the American Association for Cancer Research,
A P Chahinian, and C Nogeire, and T Ohnuma, and M L Greenberg, and M Sivak, and I S Jaffrey, and J F Holland
Phase I study of Carzelesin (U-80,244) given (4-weekly) by intravenous bolus schedule.
March 1999, British journal of cancer,
A P Chahinian, and C Nogeire, and T Ohnuma, and M L Greenberg, and M Sivak, and I S Jaffrey, and J F Holland
Phase I study of adozelesin administered by 24-hour continuous intravenous infusion.
March 1994, Journal of the National Cancer Institute,
A P Chahinian, and C Nogeire, and T Ohnuma, and M L Greenberg, and M Sivak, and I S Jaffrey, and J F Holland
Phase I and pharmacological study of acivicin by 24-hour continuous infusion.
September 1982, Cancer research,
Copied contents to your clipboard!